JDD Corner

From Port-Wine Stain Treatments to Bovine Colostrum, Telomeres, and Skin Aging
Port-Wine StainThe May issue of the Journal of Drugs in Dermatology features dermatology articles on topics ranging from treatment updates on Port-Wine stain to the protective effect that liposomal bovine colostrum exerts on skin aging using telomere length as an aging biomarker. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Authors analyze extrusion forces of various produ …
Port-Wine Stain
Prescribing Isotretinoin for Transgender Patients
isotretinoin for transgender patientsCase Scenario A 26-year-old patient presents to the dermatology clinic with severe nodulocystic scarring acne. The patient identifies as a transgender male and notes that he has been receiving hormone replacement therapy for the past 4 years with weekly intramuscular testosterone injections. He has not had any gender-affirming surgeries and reports being currently amenorrhoeic. He is curren …
isotretinoin for transgender patients
Recalcitrant Dyshidrotic Eczema Treated With Dupilumab
eczemaThe following two cases presented by JDD authors Ryan A. Gall MD, John D. Peters MD, and Alyson J. Brinker MD add to the growing literature supporting the use of dupilumab in the treatment of patients with recalcitrant dyshidrotic eczema, both with and without diagnosed contact allergens. Introduction Dyshidrotic eczema, also known as dyshidrosis or pompholyx when involving larger bullae, is a c …
eczema
From COVID-19 Vaccines and Soft Tissue Filler Reactions to Biologic Therapy for Psoriasis
JDD April 2021 IssueThe April issue of the Journal of Drugs in Dermatology features the perfect mix of medical, aesthetic, and surgical dermatology articles on topics ranging from COVID-19 Vaccines and Soft Tissue Filler Reactions to Biologic Therapy for Psoriasis. Straight from the JDD Editor’s desk, we share this month’s issue highlights: A survey was designed to capture the incidence of adverse events in G …
JDD April 2021 Issue
Tranexamic Acid to Prevent and Treat Post-Inflammatory Hyperpigmentation
Tranexamic AcidABSTRACT The risk of post-inflammatory hyperpigmentation (PIH) in patients undergoing dermatologic procedures is well known. It is especially common after laser procedures and chemical peels but can be seen with any procedure. PIH is also a sequela of acne, burns, and other trauma. High-risk patients are thought to have excessive production and abnormal distribution of melanin within the skin tha …
Tranexamic Acid